Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents

Clinical trial NCT00297817 · COMPLETED

Trial details

NCT number: NCT00297817
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningococcal Disease

Start date: 2006-02-01
Primary completion: 2007-04-01
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.